Cirtek Halts Trading Pending Investigation Findings and Delayed 2025 Results

Cirtek Holdings Limited ( (HK:1433) ) has shared an announcement.

Cirtek Holdings Limited has suspended trading in its shares on the Hong Kong Stock Exchange from 9:00 a.m. on 31 March 2026, following earlier indications of a possible delay in publishing its 2025 annual results and postponement of a board meeting. The halt will remain in place pending the release of inside information related to an ongoing investigation and the publication of the delayed financial results, with the company warning shareholders and potential investors to exercise caution and promising further updates as material developments arise.

The move underscores heightened regulatory and market sensitivity around the company’s financial disclosure and governance processes, as any prolonged suspension or adverse investigation findings could affect investor confidence, valuation, and liquidity in Cirtek’s shares. Stakeholders are now focused on the outcome of the investigation and the clarity that the eventual 2025 results will provide about the group’s operational and financial health.

The most recent analyst rating on (HK:1433) stock is a Buy with a HK$0.12 price target. To see the full list of analyst forecasts on Cirtek Holdings Limited stock, see the HK:1433 Stock Forecast page.

More about Cirtek Holdings Limited

Cirtek Holdings Limited is a Hong Kong-listed company incorporated in the Cayman Islands and traded on the Main Board of the Stock Exchange of Hong Kong under stock code 1433. The group operates through a board comprising executive and independent non-executive directors, and its shares are held by a mix of public shareholders and potential institutional investors in the regional capital market.

Average Trading Volume: 1,121,034

Technical Sentiment Signal: Buy

Current Market Cap: HK$156M

See more insights into 1433 stock on TipRanks’ Stock Analysis page.